CRIMALDDI: platform technologies and novel anti-malarial drug targets

被引：0
|
作者：
Henri Vial
Donatella Taramelli
Ian C Boulton
Steve A Ward
Christian Doerig
Kelly Chibale
机构：
[1] Université Montpellier 2,Centre National de la Recherche Scientifique, UMR 5235
[2] Università di Milano,Dipartmento di Scienze Farmacologiche e Biomolecolari
[3] TropMed Pharma Consulting Ltd,Department of Microbiology
[4] Liverpool School of Tropical Medicine,Department of Chemistry
[5] School of Biomedical Sciences,undefined
[6] Monash University,undefined
[7] University of Cape Town,undefined
来源：
Malaria Journal | / 12卷
关键词：
CRIMALDDI; Malaria; Drug discovery; Research agenda; Novel targets; Enabling technologies; Prioritization;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The Coordination, Rationalization, and Integration of antiMALarial drug Discovery & Development Initiatives (CRIMALDDI) Consortium, funded by the EU Framework Seven Programme, has attempted, through a series of interactive and facilitated workshops, to develop priorities for research to expedite the discovery of new anti-malarials. This paper outlines the recommendations for the development of enabling technologies and the identification of novel targets.
引用
收藏
相关论文
共 50 条
  • [31] The past, present and future of anti-malarial medicines
    Tse, Edwin G.
    Korsik, Marat
    Todd, Matthew H.
    MALARIA JOURNAL, 2019, 18 (1)
  • [32] The past, present and future of anti-malarial medicines
    Edwin G. Tse
    Marat Korsik
    Matthew H. Todd
    Malaria Journal, 18
  • [33] Anti-malarial, cytotoxicity and molecular docking studies of quinolinyl chalcones as potential anti-malarial agent
    Hameed, Asima
    Masood, Sara
    Hameed, Aamir
    Ahmed, Ejaz
    Sharifl, Ahsan
    Abdullah, Muhammad Imran
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2019, 33 (07) : 677 - 688
  • [34] Exploring potential of Plasmodium RUVBL proteins as anti-malarial drug target
    Khurana, Juhi
    Shrivastava, Ashish
    Singh, Ashutosh
    Gupta, Ashish
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (02) : 736 - 752
  • [35] Malaria burden and anti-malarial drug efficacy in Owando, northern Congo
    Singana, Brice P.
    Bogreau, Herve
    Matondo, Brunelle D.
    Dossou-Yovo, Louis R.
    Casimiro, Prisca N.
    Mbouka, Rigobert
    Kim Yen Ha Nguyen
    Pradines, Bruno
    Basco, Leonardo K.
    Ndounga, Mathieu
    MALARIA JOURNAL, 2016, 15
  • [36] Malaria burden and anti-malarial drug efficacy in Owando, northern Congo
    Brice P. Singana
    Hervé Bogreau
    Brunelle D. Matondo
    Louis R. Dossou-Yovo
    Prisca N. Casimiro
    Rigobert Mbouka
    Kim Yen Ha Nguyen
    Bruno Pradines
    Leonardo K. Basco
    Mathieu Ndounga
    Malaria Journal, 15
  • [37] Artesunate, an anti-malarial drug, has a potential to inhibit HCV replication
    Dai, Rongjuan
    Xiao, Xinqiang
    Peng, Feng
    Li, Mingming
    Gong, Guozhong
    VIRUS GENES, 2016, 52 (01) : 22 - 28
  • [38] Plasmodium kinase disruption: new hopes for anti-malarial drug discovery
    Malleret, Benoit
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 188 (05) : 603 - 604
  • [39] Evaluation of bioluminescence-based assays of anti-malarial drug activity
    Hasenkamp, Sandra
    Sidaway, Adam
    Devine, Oliver
    Roye, Richard
    Horrocks, Paul
    MALARIA JOURNAL, 2013, 12
  • [40] Evaluation of bioluminescence-based assays of anti-malarial drug activity
    Sandra Hasenkamp
    Adam Sidaway
    Oliver Devine
    Richard Roye
    Paul Horrocks
    Malaria Journal, 12
12345